ArticleAnnals of internal medicine2020

In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.

Sounok Sen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.